Ticker Story
RCKT
ROCKET PHARMACEUTICALS, INC.
2 independent mixed-direction signals · 36 days
2 of 8 signal types active in the last 90 days
AI Analysis
ROCKET PHARMACEUTICALS (RCKT) is showing bullish convergence driven by a single independent signal from fund positioning activity detected over the past day.
Signal Timeline
Point72 Asset Management — decrease position (-37%) · $2.3M
View primary source →Renaissance Technologies — new position · $2.7M
View primary source →Vanguard Portfolio Management — 13G, 5.35% of Rocket Pharmaceuticals Inc
View primary source →The Vanguard Group — 13G/A, 0% of Rocket Pharmaceuticals Inc
View primary source →Maverick Capital, Ltd. — 13G/A, 2.3% of Rocket Pharmaceuticals, Inc.
View primary source →The Vanguard Group — 13G/A, 7.89% of Rocket Pharmaceuticals Inc
View primary source →Maverick Capital, Ltd. — 13G/A, 7.8% of Rocket Pharmaceuticals, Inc.
View primary source →⚠ Detection and context from official public sources — not financial advice, not a prediction.